The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 05, 2018
Filed:
Sep. 20, 2016
Applicants:
Shionogi & Co., Ltd., Osaka, JP;
National Cerebral and Cardiovascular Center, Osaka, JP;
Inventors:
Assignees:
Shionogi & Co., Ltd., Osaka, JP;
National Cerebral and Cardiovascular Center, Osaka, JP;
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/25 (2006.01); A61K 31/41 (2006.01); A61K 38/22 (2006.01); A61K 45/06 (2006.01); A61K 31/4184 (2006.01); A61K 31/47 (2006.01); A61K 33/24 (2006.01); A61K 31/4178 (2006.01); A61K 31/4245 (2006.01); A61K 31/555 (2006.01); A61K 31/473 (2006.01);
U.S. Cl.
CPC ...
A61K 38/25 (2013.01); A61K 31/41 (2013.01); A61K 31/4178 (2013.01); A61K 31/4184 (2013.01); A61K 31/4245 (2013.01); A61K 31/47 (2013.01); A61K 31/473 (2013.01); A61K 31/555 (2013.01); A61K 33/24 (2013.01); A61K 38/22 (2013.01); A61K 45/06 (2013.01);
Abstract
A medicinal composition for suppressing or preventing the metastasis of a malignant tumor, the composition comprising, as an active ingredient, at least one kind of vasoprotective agent selected from the following (i) to (iv): (i) angiotensin II receptor antagonist, (ii) HMG-CoA reductase inhibitor, (iii) ghrelin or its derivative, and (iv) adrenomedullin or its derivative; or a pharmacologically acceptable salt thereof.